Welch & Forbes LLC Zoetis Inc. Transaction History

Welch & Forbes LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$151.44 - $200.09 $1,362 - $1,800	-9 Reduced 0.72%	1,248 $246,000
Q3 2023 Nov 02, 2023	BUY	$167.14 - $192.77 $5,181 - $5,975	31 Added 2.53%	1,257 $218,000
Q2 2023 Jul 28, 2023	BUY	$160.94 - $186.23 $197,312 - $228,317	1,226 New	1,226 $211,000
Q2 2022 Jul 22, 2022	BUY	$155.97 - $200.09 $2,339 - $3,001	15 Added 1.11%	1,363 $235,000
Q1 2022 Apr 25, 2022	BUY	$181.39 - $234.03 $44,984 - $58,039	248 Added 22.55%	1,348 $254,000
Q4 2021 Jan 19, 2022	BUY	$193.69 - $247.03 $1,162 - $1,482	6 Added 0.55%	1,100 $268,000
Q3 2021 Oct 13, 2021	BUY	$189.29 - $209.69 $207,083 - $229,400	1,094 New	1,094 $212,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

Stay updated on Welch & Forbes LLC with notifications on news.